Aker Solutions ASA (AKSO)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 36.64 |
|---|---|
| 52-week range | 27.08 – 48.48 |
| Return, 1 month / 3 months | −12.6% / −14.6% |
| Return, 1 year / 3 years | +41.0% / +93.5% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 33.3% |
| Worst drawdown (1 year) | -20.9% |
| Average daily value traded | 19.09M NOK |
| Dividend yield | 9.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aker Solutions ASA is a Norwegian supplier of engineering services, technology and equipment to the offshore energy industry. The company designs and builds subsea production systems, platforms and processing facilities, and provides field development studies, maintenance and modification work for oil and gas operators. Its customers are energy companies developing offshore fields, and it is based in Norway with operations in several other countries.
The shares are listed on the Oslo Stock Exchange in Norway under the code AKSO, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aker Solutions ASA (AKSO) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 36.64 on 22 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 124 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 41.0% and over the last three months it fell 14.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.6% | ||
| From 52-week high | -23.3% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.6% | ||
| 6-month return | -9.2% | ||
| 12-month return, skipping the last month | 61.3% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.9% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 19.09M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 9.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −7.0% |
|---|---|
| 1 month | −12.6% |
| 3 months | −14.6% |
| 6 months | −9.2% |
| 1 year | +41.0% |
| 3 years | +93.5% |
| 5 years | +262.0% |
Signals
| 50-day / 200-day average | 41.61 / 40.51 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.15 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Apr 2026 | NOK 3.6000 |
| 29 Apr 2025 | NOK 3.3000 |
| 25 Nov 2024 | NOK 21.0000 |
| 12 Apr 2024 | NOK 2.0000 |
| 14 Apr 2023 | NOK 1.0000 |
| 8 Apr 2022 | NOK 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.